Zolpidem MR + Estazolam
ApprovedCompleted 0 views this week 0 watching⚡ Active
Interest: 43/100
43
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Sleep Initiation and Maintenance Disorders
Conditions
Sleep Initiation and Maintenance Disorders, Primary Insomnia
Trial Timeline
May 1, 2009 → Nov 1, 2010
NCT ID
NCT00956319About Zolpidem MR + Estazolam
Zolpidem MR + Estazolam is a approved stage product being developed by Astellas Pharma for Sleep Initiation and Maintenance Disorders. The current trial status is completed. This product is registered under clinical trial identifier NCT00956319. Target conditions include Sleep Initiation and Maintenance Disorders, Primary Insomnia.
What happened to similar drugs?
20 of 20 similar drugs in Sleep Initiation and Maintenance Disorders were approved
Approved (20) Terminated (2) Active (0)
Hype Score Breakdown
Clinical
20
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00956319 | Approved | Completed |
Competing Products
20 competing products in Sleep Initiation and Maintenance Disorders